GlaxoSmithKline begins £2bn share buyback programme
It forecasts that the repurchases will boost core earnings by 6% to 8% over the coming year
GSK
-
-
Five top-performing UK equity funds quietly achieving in an unloved sector
Using FE data, Portfolio Adviser shines a spotlight on the UK equity funds delivering the strongest, most reliable returns over the long term
-
More CEOs named Andrew and Simon than female leaders in FTSE 100
Not a single female CEO of colour in the blue-chip index, according to Equality Group